These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30869490)

  • 21. The effect of critical illness on drug distribution.
    Gonzalez D; Conrado DJ; Theuretzbacher U; Derendorf H
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2030-6. PubMed ID: 21554214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients.
    Hites M; Dell'Anna AM; Scolletta S; Taccone FS
    Adv Drug Deliv Rev; 2014 Nov; 77():12-21. PubMed ID: 24842474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care Medications.
    Rowe S; Siegel D; Benjamin DK;
    Clin Ther; 2015 Sep; 37(9):1924-32. PubMed ID: 26323523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic drug monitoring--the appropriate use of drug level measurement in the care of the neonate.
    Young TE
    Clin Perinatol; 2012 Mar; 39(1):25-31. PubMed ID: 22341534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative considerations for airway management and drug dosing in obese children.
    Lerman J; Becke K
    Curr Opin Anaesthesiol; 2018 Jun; 31(3):320-326. PubMed ID: 29697466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
    Roberts JA; Lipman J
    Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling for critically ill patients: An introduction for beginners.
    Lafont E; Urien S; Salem JE; Heming N; Faisy C
    J Crit Care; 2015 Dec; 30(6):1287-94. PubMed ID: 26719063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Considerations for Drug Dosing in Premature Infants.
    van den Anker J; Allegaert K
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S141-S151. PubMed ID: 34185893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inconsistencies in dosage practice in children with overweight or obesity: A retrospective cohort study.
    Gade C; Christensen HR; Dalhoff KP; Holm JC; Holst H
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00398. PubMed ID: 29721323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics in the critically ill patient.
    Park GR
    Xenobiotica; 1993 Nov; 23(11):1195-230. PubMed ID: 8310706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
    Ha MA; Sieg AC
    Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
    Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
    J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters.
    Smit C; De Hoogd S; Brüggemann RJM; Knibbe CAJ
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):275-285. PubMed ID: 29431542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study.
    Fleuren LM; Roggeveen LF; Guo T; Waldauf P; van der Voort PHJ; Bosman RJ; Swart EL; Girbes ARJ; Elbers PWG
    Crit Care; 2019 May; 23(1):185. PubMed ID: 31118061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug therapy in childhood: what has been done and what has to be done?
    Bartels H
    Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morbid obesity is an independent determinant of death among surgical critically ill patients.
    Nasraway SA; Albert M; Donnelly AM; Ruthazer R; Shikora SA; Saltzman E
    Crit Care Med; 2006 Apr; 34(4):964-70; quiz 971. PubMed ID: 16484910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetic considerations in the elderly. An update.
    Dawling S; Crome P
    Clin Pharmacokinet; 1989 Oct; 17(4):236-63. PubMed ID: 2686883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.